Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development to deliver safe and effective medicines. Their approach is based on rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development.
